Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis
Study Overview
The main purpose of this study is to see if an experimental drug, TRADIPITANT can help people with diabetic or idiopathic gastroparesis who are suffering from nausea.
Study Description
Who is eligible? • Patients with idiopathic or diabetic gastroparesis with moderate to severe nausea • Patients must have had nausea symptoms for at least 6 months If you participate in the study you will receive the following: Physical examinations, laboratory tests, study related medications. All procedures and medication are provided at no charge to you. How long will I be in the study? The total time in the study could be up to approximately 9 weeks. Will I be paid to be in the study? Patients will be compensated for time and travel.
- Study Identifier: 829015
Recruitment Status
Enrolling By InvitationIf you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu
